ENTRY       D11405                      Drug
NAME        Prabotulinumtoxin A (USAN);
            PrabotulinumtoxinA-xvfs;
            Jeuveau (TN)
PRODUCT     JEUVEAU (Evolus)
FORMULA     C6760H10447N1743O2010S32
EXACT_MASS  149228.9908
MOL_WEIGHT  149320.8333
CLASS       Musculo-skeletal system agent
             DG02029  Muscle relaxant
              DG01696  Peripherally-acting muscle relaxant
               DG03117  Nondepolarizing neuromuscular blocking agent
REMARK      ATC code: M03AX01
            Chemical structure group: DG00772
            Product (DG00772): D00783<JP/US> D02735<JP/US> D11405<US>
EFFICACY    Skeletal muscle relaxant
COMMENT     Treatment of glabellar lines
TARGET      SNAP25 [HSA:6616] [KO:K18211]
  PATHWAY   hsa04721(6616)  Synaptic vesicle cycle
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             M MUSCULO-SKELETAL SYSTEM
              M03 MUSCLE RELAXANTS
               M03A MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
                M03AX Other muscle relaxants, peripherally acting agents
                 M03AX01 Botulinum toxin
                  D11405  Prabotulinumtoxin A (USAN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Dermatological Agents
              Dermatological Agents, Other
               Dermatological Agents, Miscellaneous
                Prabotulinumtoxin A
                 D11405  Prabotulinumtoxin A (USAN)
            Drug groups [BR:br08330]
             Musculo-skeletal system agent
              DG02029  Muscle relaxant
               DG01696  Peripherally-acting muscle relaxant
                DG03117  Nondepolarizing neuromuscular blocking agent
                 DG00772  Botulinum toxin
                  D11405  Prabotulinumtoxin A
            Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Organismal systems
               Nervous system
                SNAP25
                 D11405  Prabotulinumtoxin A (USAN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D11405
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11405
            Drug groups [BR:br08330]
             Musculo-skeletal system agent
              DG02029  Muscle relaxant
               DG01696  Peripherally-acting muscle relaxant
                DG03117  Nondepolarizing neuromuscular blocking agent
                 DG00772  Botulinum toxin
DBLINKS     CAS: 93384-43-1
            PubChem: 384585383
///
